| Title | Eugenol Inhibits the Biological Activities of an Oral Squamous Cell Carcinoma Cell Line SCC9 via Targeting MIF |
| Authors | Duan, Yao Huang, Xiaojin Qiao, Bo Ma, Rui Li, Jialin |
| Affiliation | Peking Univ, Dept Dent Ctr 2, Sch & Hosp Stomatol, Beijing 100101, Peoples R China Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis,Dept Tradit Chinese Med, 14,Sect 3,Renmin South Rd, Chengdu 610041, Sichuan, Peoples R China Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Stomatol, Beijing 100101, Peoples R China |
| Keywords | CANCER |
| Issue Date | 2022 |
| Publisher | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY |
| Abstract | Background: Oral squamous cell carcinoma (OSCC) is a rampant cancer type in head and neck cancers with a poor prognosis and a high recurrence rate. Eugenol shows an anticancer effect in a variety of cancers, but it has been rarely studied in oral squamous cell carcinoma (OSCC). Objective: The purpose of this study was to explore the role of Eugenol in OSCC and the underlying mechanism. Methods: After different concentrations of Eugenol (0, 200, 400, and 800 mu M) treatment, the viability, proliferation, migration, and invasion of OSCC cell line SCC9 were measured by CCK-8, colony formation, wound-healing, and transwell assays, respectively. TUNEL staining was employed to detect apoptosis. Western blotting was used to evaluate gene expression at the protein level. Molecular docking was used to identify the target of Eugenol. Results: Eugenol decreased the proliferation and reduced the abilities of invasion and migration along with the expression of matrix metalloproteinases (MMP) 2 and MMP9 in SCC9 cells. On the contrary, the ratio of apoptotic cells was increased by Eugenol. In addition, Eugenol down-regulated B cell lymphoma-2 (Bcl-2) expression, but up-regulated BCL-2 associated X (Bax), cleaved caspase 3, and cleaved poly-ADP ribose polymerase (PARP) expression. Meanwhile, Eugenol exerted its effect on SCC9 cells in a concentration-dependent manner. Eugenol could bind to macrophage migration inhibitory factor (MIF), the expression of which was down-regulated after Eugenol treatment. Besides, overexpression of MIF reversed all the effects of Eugenol on OSCC cells. Conclusion: In summary, Eugenol suppressed the malignant processes of OSCC cells by targeting MIF, which could guide the clinical application of Eugenol in OSCC. |
| URI | http://hdl.handle.net/20.500.11897/654625 |
| ISSN | 1871-5206 |
| DOI | 10.2174/1871520622666220324105435 |
| Indexed | SCI(E) |
| Appears in Collections: | 口腔医院 |
